| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | FQI-2 | CTRPv2 | pan-cancer | AAC | 0.05 | 0.2 |
| mRNA | BRD-K02251932 | CTRPv2 | pan-cancer | AAC | 0.06 | 0.2 |
| mRNA | MS-275 | gCSI | pan-cancer | AAC | -0.081 | 0.2 |
| mRNA | KU-55933 | CTRPv2 | pan-cancer | AAC | -0.056 | 0.2 |
| mRNA | WZ4002 | CTRPv2 | pan-cancer | AAC | 0.068 | 0.2 |
| mRNA | ML162 | CTRPv2 | pan-cancer | AAC | 0.052 | 0.2 |
| mRNA | BRD-K03536150 | CTRPv2 | pan-cancer | AAC | 0.058 | 0.2 |
| mRNA | darinaparsin | CTRPv2 | pan-cancer | AAC | -0.079 | 0.2 |
| mRNA | simvastatin | CTRPv2 | pan-cancer | AAC | -0.06 | 0.2 |
| mRNA | tandutinib | CTRPv2 | pan-cancer | AAC | 0.055 | 0.2 |